Wolf Herve Fridman

Person

Paris, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for predicting the survival time of patients suffering from...
- Patent number 11,385,231
- Issue date Jul 12, 2022
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE SCIENTIFIQUE)
- Marie-Caroline Dieu-Nosjean
- G01 - MEASURING TESTING
Information Patent Grant
In vitro method for the prognosis of progression of a cancer and of...
- Patent number 11,300,569
- Issue date Apr 12, 2022
- ISERM (Institut National de la Santé et de la Recherche Médicale)
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
In vitro method for the prognosis of progression of a cancer and of...
- Patent number 10,191,059
- Issue date Jan 29, 2019
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for the prognosis of survival time of a patient suffering fr...
- Patent number 9,851,357
- Issue date Dec 26, 2017
- INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Catherine Sautes-Fridman
- G01 - MEASURING TESTING
Information Patent Grant
Universal carrier for targeting molecules to GB3 receptor expressin...
- Patent number 9,603,923
- Issue date Mar 28, 2017
- Institut Curie
- Ludger Johannes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Universal carrier for targeting molecules to Gb3 receptor expressin...
- Patent number 8,852,612
- Issue date Oct 7, 2014
- Institute Curie
- Ludger Johannes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vitro method for the prognosis of progression of a cancer and of th...
- Patent number 8,481,271
- Issue date Jul 9, 2013
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Jérôme Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of interleukin-1β converting enzyme
- Patent number 8,119,631
- Issue date Feb 21, 2012
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of human, humanized or chimaeric antibodies or polypept...
- Patent number 7,790,399
- Issue date Sep 7, 2010
- Laboratoire Francais du Fractionnement et des Biotechnolgies (LFB)
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1β converting enzyme
- Patent number 7,790,713
- Issue date Sep 7, 2010
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Universal carrier for targeting molecules to Gb3 receptor expressin...
- Patent number 7,632,514
- Issue date Dec 15, 2009
- Institute Curie
- Ludger Johannes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1β converting enzyme
- Patent number 6,423,840
- Issue date Jul 23, 2002
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of Interleukin-1β converting enzyme
- Patent number 6,258,948
- Issue date Jul 10, 2001
- Vertex Pharmaceuticals, Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1β Converting enzyme inhibitors
- Patent number 6,204,261
- Issue date Mar 20, 2001
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1.beta. converting enzyme
- Patent number 6,162,790
- Issue date Dec 19, 2000
- Vertex Pharmaceuticals Incorporated
- Guy W. Bemis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1.beta. converting enzyme
- Patent number 6,008,217
- Issue date Dec 28, 1999
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1.beta. converting enzyme
- Patent number 5,874,424
- Issue date Feb 23, 1999
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of interleukin-1.beta.converting enzyme
- Patent number 5,843,904
- Issue date Dec 1, 1998
- Vertex Pharmaceuticals, Inc.
- Guy W. Bemis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD FOR PROGNOSIS AND TREATING A PATIENT SUFFERING FROM CANCER
- Publication number 20240229154
- Publication date Jul 11, 2024
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Lubka ROUMENINA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PROGNOSIS AND TREATING A PATIENT SUFFERING FROM CANCER
- Publication number 20240132974
- Publication date Apr 25, 2024
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Lubka ROUMENINA
- G01 - MEASURING TESTING
Information Patent Application
In Vitro Method for the Prognosis of Progression of a Cancer and of...
- Publication number 20220308063
- Publication date Sep 29, 2022
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FR...
- Publication number 20200041519
- Publication date Feb 6, 2020
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Marie-Caroline Dieu-Nosjean
- G01 - MEASURING TESTING
Information Patent Application
IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...
- Publication number 20190178892
- Publication date Jun 13, 2019
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS SUFFERING FROM...
- Publication number 20180252720
- Publication date Sep 6, 2018
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Marie-Caroline DIEU-NOSJEAN
- G01 - MEASURING TESTING
Information Patent Application
Method for the Prognosis of Survival Time of a Patient Suffering fr...
- Publication number 20160146820
- Publication date May 26, 2016
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Catherine Sautes-Fridman
- G01 - MEASURING TESTING
Information Patent Application
IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...
- Publication number 20150268245
- Publication date Sep 24, 2015
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL CARRIER FOR TARGETING MOLECULES TO GB3 RECEPTOR EXPRESSIN...
- Publication number 20150045536
- Publication date Feb 12, 2015
- INSTITUT CURIE
- Ludger JOHANNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FR...
- Publication number 20150004253
- Publication date Jan 1, 2015
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Marie-Caroline Dieu-Nosjean
- G01 - MEASURING TESTING
Information Patent Application
IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...
- Publication number 20140057257
- Publication date Feb 27, 2014
- Jerome Galon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
- Publication number 20120165319
- Publication date Jun 28, 2012
- Vertex Pharmaceuticals Incorporated.
- Mark James Batchelor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
- Publication number 20110178069
- Publication date Jul 21, 2011
- Vertex Pharmaceuticals Incorporated.
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSIN...
- Publication number 20100196418
- Publication date Aug 5, 2010
- Ludger JOHANNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vitro Method for the Prognosis of Progression of a Cancer and of th...
- Publication number 20090215053
- Publication date Aug 27, 2009
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Jérôme Galon
- G01 - MEASURING TESTING
Information Patent Application
Inhibitors of interleukin-1beta converting enzyme
- Publication number 20080039449
- Publication date Feb 14, 2008
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic products with enhance ability to immunomodulate cell fu...
- Publication number 20070135621
- Publication date Jun 14, 2007
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of interleukin-1beta converting enzyme
- Publication number 20050143436
- Publication date Jun 30, 2005
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Universal carrier for targeting molecules to Gb3 receptor expressin...
- Publication number 20040110935
- Publication date Jun 10, 2004
- Ludger Johannes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of interleukin-1beta converting enzyme
- Publication number 20030225269
- Publication date Dec 4, 2003
- Vertex Pharmaceuticals Incorporated
- Mark James Batchelor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Wolf Herve Fridman

Person

Patents Grantslast 30 patents

Methods for predicting the survival time of patients suffering from...

In vitro method for the prognosis of progression of a cancer and of...

In vitro method for the prognosis of progression of a cancer and of...

Method for the prognosis of survival time of a patient suffering fr...

Universal carrier for targeting molecules to GB3 receptor expressin...

Universal carrier for targeting molecules to Gb3 receptor expressin...

Vitro method for the prognosis of progression of a cancer and of th...

Inhibitors of interleukin-1β converting enzyme

Preparation of human, humanized or chimaeric antibodies or polypept...

Inhibitors of interleukin-1β converting enzyme

Universal carrier for targeting molecules to Gb3 receptor expressin...

Inhibitors of interleukin-1&#x03B2; converting enzyme

Inhibitors of Interleukin-1&#x03B2; converting enzyme

Inhibitors of interleukin-1&#x03B2; Converting enzyme inhibitors

Inhibitors of interleukin-1.beta. converting enzyme

Inhibitors of interleukin-1.beta. converting enzyme

Inhibitors of interleukin-1.beta. converting enzyme

Inhibitors of interleukin-1.beta.converting enzyme

Patents Applicationslast 30 patents

METHOD FOR PROGNOSIS AND TREATING A PATIENT SUFFERING FROM CANCER

METHOD FOR PROGNOSIS AND TREATING A PATIENT SUFFERING FROM CANCER

In Vitro Method for the Prognosis of Progression of a Cancer and of...

METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FR...

IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...

METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS SUFFERING FROM...

Method for the Prognosis of Survival Time of a Patient Suffering fr...

IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...

UNIVERSAL CARRIER FOR TARGETING MOLECULES TO GB3 RECEPTOR EXPRESSIN...

METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FR...

IN VITRO METHOD FOR THE PROGNOSIS OF PROGRESSION OF A CANCER AND OF...

INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME

INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME

UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSIN...

Vitro Method for the Prognosis of Progression of a Cancer and of th...

Inhibitors of interleukin-1beta converting enzyme

Therapeutic products with enhance ability to immunomodulate cell fu...

Inhibitors of interleukin-1beta converting enzyme

Universal carrier for targeting molecules to Gb3 receptor expressin...

Inhibitors of interleukin-1beta converting enzyme

Inhibitors of interleukin-1β converting enzyme

Inhibitors of Interleukin-1β converting enzyme

Inhibitors of interleukin-1β Converting enzyme inhibitors